Factor Meals Menu
US$ 22.96
glp 1 and glp 2 drugs GLP-1 receptor agonists How GLP-1 medications are transforming
Description
J Endocrinol 2023, 258(2)
A multistrain probiotic reduces sarcopenia by modulating Wnt signaling biomarkers in patients with chronic heart failure
Patients were also less likely to die or require hospitalization when taking GLP-1 drugs, the study found
GLP-1RA interventions may reduce the incidence of recurrent AP, particularly SEMA and tirzepatide
Yet cardiomyocytes, the main muscle cells of the heart, and hepatocytes in the liver do not appear to express GLP-1 or GIP receptors in significant amounts
He is an advisory board member to CytoDyn
